16424-76-3

Basic information

• Product Name: Butanamide, N-cyclohexyl-2,4-dihydroxy-3,3-dimethyl-
• CAS NO: 16424-76-3
• Molecular Formula: C12H23NO3
• Molecular Weight: 229.32
• Mol File: 16424-76-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Butanamide, N-cyclohexyl-2,4-dihydroxy-3,3-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanamide, N-cyclohexyl-2,4-dihydroxy-3,3-dimethyl-(16424-76-3)
• EPA Substance Registry System: Butanamide, N-cyclohexyl-2,4-dihydroxy-3,3-dimethyl-(16424-76-3)

Safety Data

• Hazardous Substances Data: 16424-76-3(Hazardous Substances Data)

Upstream product

• 108-91-8 cyclohexylamine 
• 79-50-5 pantolactone 
• 264620-50-0 2-hydroxy-3,3-dimethyl-cyclopentanone 

Downstream Products

• 100396-14-3 phosphoric acid mono-(3-cyclohexylcarbamoyl-3-hydroxy-2,2-dimethyl-propyl ester) 
• 111473-98-4 phosphoric acid benzyl ester-(3-cyclohexylcarbamoyl-3-hydroxy-2,2-dimethyl-propyl ester) 
• 886616-34-8 toluene-4-sulfonic acid 1-cyclohexyl-4,4-dimethyl-2-oxo-pyrrolidin-3-yl ester 
• 115018-83-2 1-cyclohexyl-4,4-dimethylpyrrolidine-2,3,5-trione 
• 122724-15-6 diphosphoric acid mono-(3-cyclohexylcarbamoyl-3-hydroxy-2,2-dimethyl-propyl ester) 

Relevant articles and documents

CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1

The present invention discloses compounds of Formula I: (I) having 11beta -HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as the use of the Fomula I and compositions as medicaments to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, Syndrome X, and other conditions associated with hyperglycemia.

Pantothenic acid derivatives.

-